Headline News about Celldex Therapeutics
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Expectations For Celldex Therapeutics's Future
June 03, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Unveiling 4 Analyst Insights On Celldex Therapeutics
May 07, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/03/01/image17.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Celldex Therapeutics: Q4 Earnings Insights
February 26, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Forecasting The Future: 5 Analyst Projections For Celldex Therapeutics
December 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
What 7 Analyst Ratings Have To Say About Celldex Therapeutics
November 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/02/26/image10.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/07/Stock-celldex-01-shutt.jpg)
![](https://cdn.pixabay.com/photo/2014/12/10/20/48/medic-563425_960_720.jpg)
![](/next-assets/images/schema-image-default.png)
Celldex Therapeutics: Q1 Earnings Insights
May 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/27/cldx.jpg?width=1200&height=800&fit=crop)
Why Celldex Therapeutics Shares Are Trading Higher Today
February 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_4119.jpeg?width=1200&height=800&fit=crop)
Celldex Therapeutics Earnings Perspective: Return On Capital Employed
December 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/20/image10.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://cdn.benzinga.com/files/images/story/2023/11/08/1.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/754016/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg)
![](https://www.investors.com/wp-content/uploads/2022/07/Stock-celldex-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/06/cldx.jpg?width=1200&height=800&fit=crop)
Why Is Inflammation Disease-Focused Celldex Therapeutics Stock Trading Higher Today?
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/06/image42.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 06, 2023
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Wall Street's Top 10 Stock Calls This Week - Sunday, Aug. 27
August 27, 2023
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
August 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/05/11/shutterstock_1392128159.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/options_image_824.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/27/image20.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/01/percentage_stock_image.jpg?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/810130982/ZngKuwZX.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.